Noxopharm Limited ( ASX:NOX) provides shareholders with a video interview with CEO Dr Graham Kelly explaining the discovery of idronoxil-C.
To view the interview, please visit the link below:
www.finnewsnetwork.com.au/MediaCenter/AsxMediaCenter.aspx?Site=FNN922
For further information please download PDF attached:
Download this document
